Nakamoto (NAKA) vs Starling Oncology (STLN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Starling Oncology (STLN) has outperformed Nakamoto (NAKA) over the past year, gaining 55.7% versus a loss of 76.7%. Starling Oncology is the larger company by market cap ($684.9 million vs $160.0 million), about 4.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NAKA | STLN |
|---|---|---|
| Share price | $8.94 | $6.72 |
| Market cap | $159.98M | $684.88M |
| 1-day change | +0.11% | +8.74% |
| YTD return | -36.40% | +73.60% |
| 1-year return | -76.74% | +55.67% |
| 5-year return | — | -37.89% |
| P/E ratio (TTM) | 4.78 | — |
| EPS (TTM) | $1.87 | $-0.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $42.00 | $7.13 |
| 52-week low | $3.33 | $2.32 |
| Distance from 52-week high | -78.71% | -5.75% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +49.11% | +33.93% |
| Average volume | 202.93K | 1.53M |
| Shares outstanding | 17.89M | 101.92M |
| Employees | 33 | 641 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Starling Oncology is about 4.3 times larger than Nakamoto by market value ($684.88M vs $159.98M).
- STLN has outperformed NAKA by 132.4 percentage points over the past year.
About Nakamoto
NAKA stock →Nakamoto Inc. develops and invests in a global portfolio of Bitcoin-native companies.
Health Care · Medical/Nursing Services · 33 employees
About Starling Oncology
STLN stock →Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.
Health Care · Medical/Nursing Services · 641 employees
NAKA vs STLN FAQ
Which is bigger, Nakamoto or Starling Oncology?
Starling Oncology (STLN) is larger, with a market capitalization of $684.88M compared with $159.98M for Nakamoto (NAKA).
Which stock has performed better over the past year, NAKA or STLN?
STLN returned +55.67% over the past 12 months, compared with -76.74% for NAKA (price return, excluding dividends). Past performance does not predict future results.
Are Nakamoto and Starling Oncology in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.